skin care
Medications
Instructed in new medication Bactroban to manage wound care. In addition, warned of possible S/E such as headache, rhinitis, pharyngitis, burning or stinging with intranasal use, taste perversion, upper respiratory tract congestion, cough with intranasal use, burning pruritis, stinging, rash, pain, and erythema with topical use. Instructed to notify prescriber immediately if no improvement occurs in 3 to 5 days or if condition worsens. Advised not to use other nasal products with Bactroban. Warned patient about local adverse reactions related to drug use. Advised not to use cosmetics or other skin products on treated area.
SN advised patient call your doctor or nurse call line now or seek immediate medical care if: You have new bruises that are away from the injection site or blood spots under your skin, you have a nosebleed., you have blood in your urine.Your stools are black and tar-like or have streaks of blood, you have vaginal bleeding when you are not having your period, or heavy period bleeding.
SN instructed patient / caregiver about Methylprednisolone ( Medrol ), it is a corticosteroid used to treat severe allergies, arthritis, asthma, and skin conditions. It may also be used to treat other conditions as determined by your doctor. Possible side effects, that may go away during treatment, include difficulty sleeping, mood changes, nervousness, increased appetite, or indigestion. If they continue or are bothersome, check with your doctor. Check with your doctor as soon as possible if you experience swelling of feet or legs unusual weight gain black, tarry stools vomiting material that looks like coffee grounds severe nausea or vomiting changes in menstrual periods headache muscle weakness or prolonged sore throat, cold or fever. If you notice other effects not listed above, contact your doctor, nurse, or pharmacist. DO NOT stop taking this medicine without checking with your doctor. Stopping this medicine suddenly may cause serious side effects. Keep all doctor and laboratory appointments while you are using this medicine. Before you have any medical or dental treatments, emergency care, or surgery, tell the doctor or dentist that you are using this medicine. This medicine makes you more susceptible to illnesses, especially if you take it for an extended period of time. Prevent infection by avoiding contact with people who have colds or other infections. Report any injuries or signs of infection (fever, sore throat, pain during urination, or muscle aches) that occur during treatment and within 12 months after stopping this medicine.
Patient was educated about Digoxin 0.125 mg 1 tablet oral daily, instruct to take medication exactly as directed, at the same time each day. Missed doses should be taken within 12 hr of scheduled dose or not taken at all. Do not double doses. Consult health care professional if doses for 2 or more days are missed. Do not discontinue medication without consulting health care professional.
Fludrocortisone is a corticosteroid. It works by causing the kidneys to retain sodium and acting as a replacement for cortisone when the body does not produce enough.Carry an ID card at all times that says you take fludrocortisone. Tell your doctor or dentist that you take fludrocortisone before you receive any medical or dental care, emergency care, or surgery.Fludrocortisone may cause an increase in blood pressure, salt and water retention, and calcium and potassium loss. Talk with your doctor to see if you need to decrease the amount of salt in your diet or take a calcium or vitamin D supplement. Check with your doctor if any of these most common side effects persist or become bothersome:Difficulty sleeping; dizziness or lightheadedness; headache; increased appetite; increased sweating; indigestion; nervousness
SN instructed patient that Xifaxan is used for cessation of traveler's diarrhea and the reduction in risk of overt hepatic encephalopathy. Side effects are dizziness and peripheral edema. SN instructed patient to take rifaximin as directed and to complete therapy, even if feeling better. Caution patient to stop taking rifaximin if diarrhea symptoms get worse, persist more than 24–48 hr or are accompanied by fever or blood in the stool. Consult health care professional if these occur. Advise patient not to treat diarrhea without consulting health care professional. May occur up to several weeks after discontinuation of medication. Caution patient to avoid driving and other activities requiring alertness until response to medication is known.
Instructed in new medication Sulfaprim and in S/E such as headache, mental depression, aseptic meningitis, tinnitus, apathy, seizures, hallucinations, ataxia, nervousness, fatigue, vertigo, insomnia, thrombophlebitis, nausea, vomiting, diarrhea, abdominal pain, anorexia, stomatitis, pancreatitis, pseudomembranous colitis, toxic nephrosis with oliguria and anuria, crystalluria, hematuria, interstitial nephritis, agranulocytosis, aplastic anemia, megaloblastic anemia, thrombocytopenia, leukopenia, hemolytic anemia, jaundice, hepatic necrosis, arthralgia, myalgia, muscle weakness, pulmonary infiltrates, erythema multiforme, Stevens-Johnson syndrome, generalized skin eruption, toxic epidermal necrolysis, exfoliative dermatitis, photosensitivity, urticaria, pruritus, hypersensitivity reactions, serum sickness, drug fever and anaphylaxis.
Instructed in new medication Prevacid and in S/E such as headache, dizziness, vertigo, malaise, paresthesia, fever, palpitations, flushing, orbital edema, tinnitus, diarrhea, constipation, anorexia, taste perversion, dry mouth, bone and muscle pain, acne, dry skin and transient irritation at I.V. site.
Instructed in new medication Prednisone and in S/E such as euphoria, insomnia, psychotic behavior, vertigo, headache, paresthesia, seizures, pseudotumor cerebri, heart failure, hypertension, edema, arrhythmias, thrombophlebitis, thromboembolism, cataracts, glaucoma, peptic ulceration, GI irritation, increased appetite, pancreatitis, nausea, vomiting, menstrual irregularities, increased urine calcium levels, hypokalemia, hyperglycemia, carbohydrate intolerance, growth suppression in children, muscle weakness, osteoporosis, hirsutism, delayed wound healing, acne and various skin eruptions.
Instructed in new medication Augmentin to manage infection. In addition, warned of possible S/E such as nausea, vomiting, headache, dizziness, skin rash, blurred vision, confusion, anxiety, redness, etc.